Adherence to Immunomodulators in Multiple Sclerosis: Prevalence and Clinical Impact (the AIMS Study)

Project number: 
12-011
Approval date: 
Thursday, February 28, 2013
Principal Investigator: 
Tremlett,Helen
Institution: 
University of British Columbia (UBC)
Funding Agency: 
National Multiple Sclerosis Society
Datasets requested: 
PharmaNet
Hospital Separations (BC Ministry of Health)
Consolidation - demographic (Ministry of Health)
Deaths (BC Vital Statistics Agency)
Consolidation registry (Ministry of Health)
ACG Case Mix Group (Johns Hopkins University)
Medical Services Plan (BC Ministry of Health)
consolidation - census geocodes
Research objective: 
Publications: 

Journal Publication

  • Charity Evans, Ruth Ann Marrie, Feng Zhu, Stella Leung, Xinya Lu, Elaine Kingwell, Yinshan Zhao, Helen Tremlett. 2017. Adherence to Disease Modifying Therapies for Multiple Sclerosis and Subsequent Hospitalizations. Pharmacoepidemiology and Drug Safety (in press)
  • Charity Evans, Ruth Ann Marrie, Feng Zhu, Stella Leung, Xinya Lu, Elaine Kingwell, Yinshan Zhao, Helen Tremlett. 2016. Adherence and persistence to drug therapies for multiple sclerosis: A population-based study. Multiple Sclerosis and Related Disorders, 8; 78-85

Presentation of research material (poster/seminar/lecture etc.)

  • C. Evans, R.A. Marrie, S. Leung, F. Zhu, X. Lu, H. Tremlett. The Impact of Adherence to Immunomodulators on Hospitalisations in Multiple Sclerosis. 2015 European Committee for Treatment and Research in Multiple Sclerosis Congress, Barcelona, Spain, October 8, Abstract to be published in Multiple Sclerosis Journal.  

Conference abstract/presentation

  • C. Evans, R.A. Marrie, S. Leung, F. Zhu, X. Lu, H. Tremlett. Persistence and Adherence to Immunomodulators Varies Between Canadian Provinces. 2015 European Committee for Treatment and Research in Multiple Sclerosis Congress, Barcelona, Spain, October 8, Abstract to be published in Multiple Sclerosis Journal.
     

Page last revised: December 5, 2017